Bioventus Inc. (BVS)
BVS Stock Price Chart
Explore Bioventus Inc. interactive price chart. Choose custom timeframes to analyze BVS price movements and trends.
BVS Company Profile
Discover essential business fundamentals and corporate details for Bioventus Inc. (BVS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
11 Feb 2021
Employees
930.00
Website
https://www.bioventus.comCEO
Robert E. Claypoole
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
BVS Financial Timeline
Browse a chronological timeline of Bioventus Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is $0.12, while revenue estimate is $137.64M.
Earnings released on 6 Aug 2025
EPS came in at $0.21 falling short of the estimated $0.22 by -4.55%, while revenue for the quarter reached $147.66M , beating expectations by +6.40%.
Earnings released on 6 May 2025
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $123.88M , missing expectations by -15.07%.
Earnings released on 11 Mar 2025
EPS came in at $0.15 surpassing the estimated $0.08 by +87.50%, while revenue for the quarter reached $153.64M , beating expectations by +23.41%.
Earnings released on 5 Nov 2024
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $138.96M , missing expectations by -4.05%.
Earnings released on 6 Aug 2024
EPS came in at $0.19 surpassing the estimated $0.07 by +171.43%, while revenue for the quarter reached $151.22M , beating expectations by +9.90%.
Earnings released on 7 May 2024
EPS came in at $0.07 surpassing the estimated -$0.05 by +240.00%, while revenue for the quarter reached $129.46M , beating expectations by +9.36%.
Earnings released on 12 Mar 2024
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $135.42M , beating expectations by +9.25%.
Earnings released on 7 Nov 2023
EPS came in at $0.05 falling short of the estimated $0.06 by -16.67%, while revenue for the quarter reached $120.79M , missing expectations by -2.55%.
Earnings released on 8 Aug 2023
EPS came in at $0.14 surpassing the estimated $0.03 by +366.67%, while revenue for the quarter reached $137.07M , beating expectations by +6.07%.
Earnings released on 16 May 2023
EPS came in at -$0.26 falling short of the estimated -$0.11 by -136.36%, while revenue for the quarter reached $119.06M , beating expectations by +2.13%.
Earnings released on 31 Mar 2023
EPS came in at -$0.06 falling short of the estimated $0.05 by -220.00%, while revenue for the quarter reached $125.83M , missing expectations by -5.17%.
Earnings released on 21 Nov 2022
EPS came in at $0.05 falling short of the estimated $0.13 by -61.54%, while revenue for the quarter reached $128.66M , missing expectations by -9.13%.
Earnings released on 11 Aug 2022
EPS came in at $0.10 falling short of the estimated $0.14 by -28.57%, while revenue for the quarter reached $140.33M , beating expectations by +1.44%.
Earnings released on 10 May 2022
EPS came in at $0.04 falling short of the estimated $0.05 by -16.67%, while revenue for the quarter reached $117.29M , missing expectations by -0.34%.
Earnings released on 10 Mar 2022
EPS came in at $0.26 surpassing the estimated $0.20 by +30.00%, while revenue for the quarter reached $130.41M , beating expectations by +0.14%.
Earnings released on 9 Nov 2021
EPS came in at $0.25 surpassing the estimated $0.13 by +92.31%, while revenue for the quarter reached $108.89M , beating expectations by +3.75%.
Earnings released on 10 Aug 2021
EPS came in at $0.16 surpassing the estimated $0.10 by +60.00%, while revenue for the quarter reached $109.82M , meeting expectations.
Earnings released on 12 May 2021
EPS came in at -$0.02 falling short of the estimated -$0.01 by -57.85%, while revenue for the quarter reached $81.78M , missing expectations by -82.91%.
Earnings released on 25 Mar 2021
EPS came in at $2.32 surpassing the estimated $0.23 by +908.70%, while revenue for the quarter reached $98.59M .
Earnings released on 12 Feb 2021
EPS came in at $0.15 , while revenue for the quarter reached $85.91M .
BVS Stock Performance
Access detailed BVS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.